TNFRSF1B and cancer: While inhibiting TNFR2 activities in Tregs or even destroying Tregs may be the goal in cancer, stimulating TNFR2 may be the aim to treat inflammatory conditions or inflammation-associated cancer to improve immune suppression by Tregs.